PMBI Pharmaceutical Drug Supply: Diclofenac, Paracetamol, Serratiopeptidase Tablets

Work Description - Limited E-tender For The Supply Of Drug Code-613 (diclofenac Potassium 50mg, Paracetamol 325mg And Serratiopeptidase 10mg Tablets) To Pmbi.

The Bureau of Pharma PSUs of India (BPPI), operating as a Central Government Ministry/Department, has issued a Limited e-Tender (Reference No: PMBI/DRUG/LTD.-231/2026, Tender ID: 2026_BPPI_913350_1) for the supply of specific pharmaceutical products. This procurement seeks qualified suppliers for Drug Code-613, which includes Diclofenac Potassium 50mg, Paracetamol 325mg, and Serratiopeptidase 10mg Tablets, destined for PMBI. Classified as a 'Goods' tender under the 'Drugs and Pharmaceutical Products' category, this is an 'Item Rate' contract with an estimated Tender Value of ₹50,00,000. A mandatory Earnest Money Deposit (EMD) of ₹1,00,000 is required, payable to the Office of PMBI at Delhi. Acceptable payment instruments for EMD include Demand Draft, RTGS, NEFT, Bankers Cheque, and Bank Guarantee. There is no Tender Fee applicable for this tender. Key dates for this e-Tender are as follows: It was e-Published on 16-Jun-2026 at 06:00 PM, with document download and clarification periods commencing concurrently. The clarification period concludes on 19-Jun-2026 at 05:00 PM. Bidders can download documents until 23-Jun-2026 at 05:00 PM. Bid submission opened on 17-Jun-2026 at 12:00 PM and will close on 23-Jun-2026 at 05:00 PM. The bids are scheduled to be opened on 25-Jun-2026 at 04:00 PM. The bidding process requires submissions in two covers: Cover 1 for Fee/Pre-Qualification/Technical documents (including the tender document, NIT, and additional documents in .pdf format), and Cover 2 for the Finance details (BOQ in .xls format). Bids will remain valid for 60 days, and the estimated period of work is 30 days. All specific addresses for the Tender Inviting Authority, bid opening place, and location are as detailed in the tender document.